BK0023 (Filgrastim biosimilar candidate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BK0023 (Filgrastim biosimilar candidate), covering 2013-09-09 to 2013-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the Test Injectable Formulation BK0023 vs. Neupogen® [Phase 1]